Author:
Sandoval Elena,Pereda Daniel
Abstract
Heart transplant is the gold-standard treatment for end-stage heart failure. However, the aging of the population, increase in the prevalence of heart failure and the shortage of available donors have led to a significant increase in the wait-list times. This increase in waiting time may cause some patients clinically deteriorate while on the list. Several bridging strategies have been developed to help patients reach heart transplant. It is mandatory to know the current results of these techniques and the specific tips and tricks these different devices may have. Survival results would also be presented to help us decide the best strategy for each of our patients.
Reference45 articles.
1. Barnard CN. Human heart transplantation. Canadian Medical Association Journal. 1969;100:91-104
2. Baumgartner WA, Reitz BA, Bieber CP, Oyer PE, Shumway NE, Stinson EB. Current expectations in cardiac transplantation. The Thoracic and Cardiovascular Surgeon. 1978;75:525-530
3. Oyer PE, Stinson EB, Jamieson SW, et al. Cyclosporine a in cardiac allografting: A preliminary experience. Transplantation Proceedings. 1983;15:1247-1252
4. Khush KK, Cherikh WS, Chambers DC, Goldfarb S, Hayes D, Kucheryavava AY, et al. The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult heart transplantation report- 2018; focus theme: Multiorgan transplantation. The Journal of Heart and Lung Transplantation. 2018;37(10):1155-1206
5. Samsky MD, Patel CB, Owen A, Schulte PJ, Jentzer J, Rosember PB, et al. Ten-year experience with extended criteria cardiac transplantation. Circulation. Heart Failure. 2013;6(6):1230-1238. DOI: 10.1161/CIRCHEARTFAILURE.113.000296